This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.
Patients with multiple myeloma
Number of approved sites
The MRDR was well represented at the Blood 2019 conference in Perth in October with multiple oral presentations, the MRDR interest group breakfast and presence at the Monash University booth.Read more
The MRDR had a busy and productive meeting at the IMW in Boston, USA.Read more